Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H16ClN3O3 |
InChIKeyMDHSFSUMZBWHRU-UHFFFAOYSA-N |
CAS Registry2324145-23-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 01 Mar 2019 |